These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24669769)

  • 61. A Simple Model-Based Approach to Inferring and Visualizing Cancer Mutation Signatures.
    Shiraishi Y; Tremmel G; Miyano S; Stephens M
    PLoS Genet; 2015 Dec; 11(12):e1005657. PubMed ID: 26630308
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Finding driver pathways in cancer: models and algorithms.
    Vandin F; Upfal E; Raphael BJ
    Algorithms Mol Biol; 2012 Sep; 7(1):23. PubMed ID: 22954134
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Exploring preferred amino acid mutations in cancer genes: Applications to identify potential drug targets.
    Anoosha P; Sakthivel R; Michael Gromiha M
    Biochim Biophys Acta; 2016 Feb; 1862(2):155-65. PubMed ID: 26581171
    [TBL] [Abstract][Full Text] [Related]  

  • 64. driveR: a novel method for prioritizing cancer driver genes using somatic genomics data.
    Ülgen E; Sezerman OU
    BMC Bioinformatics; 2021 May; 22(1):263. PubMed ID: 34030627
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Multi-Omic Data Improve Prediction of Personalized Tumor Suppressors and Oncogenes.
    Sudhakar M; Rengaswamy R; Raman K
    Front Genet; 2022; 13():854190. PubMed ID: 35620468
    [TBL] [Abstract][Full Text] [Related]  

  • 66. GOSemSim: an R package for measuring semantic similarity among GO terms and gene products.
    Yu G; Li F; Qin Y; Bo X; Wu Y; Wang S
    Bioinformatics; 2010 Apr; 26(7):976-8. PubMed ID: 20179076
    [TBL] [Abstract][Full Text] [Related]  

  • 67. QuaDMutNetEx: a method for detecting cancer driver genes with low mutation frequency.
    Bokhari Y; Alhareeri A; Arodz T
    BMC Bioinformatics; 2020 Mar; 21(1):122. PubMed ID: 32293263
    [TBL] [Abstract][Full Text] [Related]  

  • 68. SigsPack, a package for cancer mutational signatures.
    Schumann F; Blanc E; Messerschmidt C; Blankenstein T; Busse A; Beule D
    BMC Bioinformatics; 2019 Sep; 20(1):450. PubMed ID: 31477009
    [TBL] [Abstract][Full Text] [Related]  

  • 69. gcMECM: graph clustering of mutual exclusivity of cancer mutations.
    Hu Y; Yan C; Chen Q; Meerzaman D
    BMC Bioinformatics; 2021 Dec; 22(1):592. PubMed ID: 34906079
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Structural and functional impact of cancer-related missense somatic mutations.
    Shi Z; Moult J
    J Mol Biol; 2011 Oct; 413(2):495-512. PubMed ID: 21763698
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prediction and prioritization of rare oncogenic mutations in the cancer Kinome using novel features and multiple classifiers.
    U M; Talevich E; Katiyar S; Rasheed K; Kannan N
    PLoS Comput Biol; 2014 Apr; 10(4):e1003545. PubMed ID: 24743239
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Domain landscapes of somatic mutations in cancer.
    Nehrt NL; Peterson TA; Park D; Kann MG
    BMC Genomics; 2012 Jun; 13 Suppl 4(Suppl 4):S9. PubMed ID: 22759657
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Somatic Mutation Profiling in Head and Neck Paragangliomas.
    Savvateeva M; Kudryavtseva A; Lukyanova E; Kobelyatskaya A; Pavlov V; Fedorova M; Pudova E; Guvatova Z; Kalinin D; Golovyuk A; Bulavkina E; Katunina I; Krasnov G; Snezhkina A
    J Clin Endocrinol Metab; 2022 Jun; 107(7):1833-1842. PubMed ID: 35460558
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Low-rank representation with adaptive graph regularization.
    Wen J; Fang X; Xu Y; Tian C; Fei L
    Neural Netw; 2018 Dec; 108():83-96. PubMed ID: 30173056
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Understanding oncogenicity of cancer driver genes and mutations in the cancer genomics era.
    Porta-Pardo E; Valencia A; Godzik A
    FEBS Lett; 2020 Dec; 594(24):4233-4246. PubMed ID: 32239503
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.
    Yang H; Wei Q; Zhong X; Yang H; Li B
    Bioinformatics; 2017 Feb; 33(4):483-490. PubMed ID: 27797769
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of coding and non-coding mutational hotspots in cancer genomes.
    Piraino SW; Furney SJ
    BMC Genomics; 2017 Jan; 18(1):17. PubMed ID: 28056774
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A systematic comparison of genome-scale clustering algorithms.
    Jay JJ; Eblen JD; Zhang Y; Benson M; Perkins AD; Saxton AM; Voy BH; Chesler EJ; Langston MA
    BMC Bioinformatics; 2012 Jun; 13 Suppl 10(Suppl 10):S7. PubMed ID: 22759431
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Attributed graph clustering with multi-task embedding learning.
    Zhang X; Liu H; Zhang X; Liu X
    Neural Netw; 2022 Aug; 152():224-233. PubMed ID: 35537219
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular Signatures of
    Hsu J; Annunziata JF; Burns E; Bernicker EH; Olsen RJ; Thomas JS
    Clin Pathol; 2022; 15():2632010X221102054. PubMed ID: 35634237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.